Corient Capital Partners, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Corient Capital Partners, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$12,000
-85.9%
10,874
-76.7%
0.00%
-83.3%
Q3 2021$85,000
-30.9%
46,627
-0.2%
0.01%
-33.3%
Q2 2021$123,000
+6.0%
46,698
+44.8%
0.01%
-10.0%
Q1 2021$116,000
+41.5%
32,2580.0%0.01%
+25.0%
Q4 2020$82,00032,2580.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders